You are here: All Products  > Gland Pharma, Fosun's Indian Subsidiary, Approved for $814 Million IPO

Gland Pharma, Fosun's Indian Subsidiary, Approved for $814 Million IPO

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products